StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CRSTCHM.BO$136.00+1.97%
Fair $136.00+0.0%

CRSTCHM.BO

Crestchem Limited

Basic Materials / Specialty ChemicalsBSE

$136.00

+2.40 (+1.97%)

Fairly Valued+0.0%Fair Value $136.00Fund rank 31/100 · Data gapFallback financials|
SA 50/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $15.2M · quality 52.7/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 62/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · CRSTCHM.BOLocal privado en este navegador · Crestchem Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$408M

P/E

18.3x

↑

EV/EBITDA

10.7x

↓

ROE

36.5%

↑

Gross Margin

25.0%

↑

Debt/Equity

N/A

•
52-Week Range$136
$73$195

TradingView lightweight chart

CRSTCHM.BO price, volumen y niveles de valoración

Último $124.00Periodo -53.5%
Fair value: $136.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+46.6%

FCF CAGR

+23.0%

FCF margin

6.1%

FCF / Net income

0.56x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $250.2M · net income $27.3M · FCF $15.2M

2022-FY → 2025-FY

Gross margin

25.0%+2.1% pts

Operating margin

13.1%+4.0% pts

Net margin

10.9%+3.8% pts

FCF margin

6.1%-4.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$250.2M$250.2M$211.8M$166.3M$79.5M
Net Income$27.3M$27.3M$21.5M$6.9M$5.7M
EBITDA$37.6M$37.6M$30.3M$9.7M$8.2M
EPS9.099.097.152.311.89
Gross Margin25.0%25.0%24.0%13.2%22.9%
Operating Margin13.1%13.1%12.9%4.8%9.1%
Net Margin10.9%10.9%10.1%4.2%7.1%
Balance Sheet
Debt/Equity————0.13
Cash Flow
Free Cash Flow$15.2M$15.2M$2.3M$21.9M$8.2M
Returns
ROE36.5%36.5%43.8%25.2%27.5%
Valuation
P/E18.3318.33———
EV/EBITDA10.6510.65———
P/B5.465.46———
Growth & Yield
Revenue Growth18.1%18.1%27.4%109.2%—
EPS Growth27.0%27.0%209.4%22.3%—
Dividend Yield0.8%0.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

9.9%

razonable

EPS terminal req.

$12.07

Spread vs growth

17.1%

5Y implied EPS CAGR

9.9%

razonable

EPS terminal req.

$14.60

Spread vs growth

17.1%

10Y implied EPS CAGR

10.0%

razonable

EPS terminal req.

$23.52

Spread vs growth

17.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -33.6%

Total return

-33.6%

Start / end P/E

26.4x → 13.6x

EPS bridge

7.15 → 9.09

Residual

-13.1%

EPS growth+27.0%
Multiple rerating-48.4%
Dividend+0.8%
Residual / FX / buybacks / cross-term-13.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.